OLIGO 2020 OXFORD Virtual

Oxford Symposia - 6th Annual

OLIGO 2020 OXFORD | Virtual

Antisense & Therapeutic Nucleic Acids

03rd December 2020

Twitter: @LPMHealthcare, #OligoOx20V

Welcome to OLIGO 2020 Oxford | Virtual

We are delighted to welcome you to our 6th annual Oxford Symposium on antisense and therapeutic oligonucleotides, which will be held virtually.

The symposium is aimed at bringing together chemists and biologists from academia and industry to discuss the latest advances and breakthroughs in the development of synthetic oligonucleotides as therapeutics (see confirmed speakers).

The symposium agenda topics will include THERAPEUTIC APPLICATIONS AND DELIVERY STRATEGIES of synthetic oligonucleotides, including:

>Antisense & catalytic oligonucloetides, aptamers, siRNAs, miRNAs, antagomirs
>Chemical modifications
>In vitro/in vivo applications
>Delivery strategies
>New technologies

We particularly encourage final year doctoral students and early/mid-career postdoctoral researchers/junior group leaders to submit abstracts, as we believe this event will provide their research an excellent exposure, critical analysis by attending senior researchers and new career opportunities. Please contact us on OligoOxford@gmail.com with your presentation theme/abstract for pre-approval, or if you have any other questions.

If your abstract was accepted for a presentation at the Spring 2020 in-person meeting, and you would like to present your work in this virtual version of the meeting, please get in touch by emailing OligoOxford@gmail.com.

Please use this Abstract Template if you are submitting an abstract.

Scientific Advisers

Dr Marcel Hollenstein, Pasteur Institute, France
Dr Sylvain Ladame, Imperial College London, UK
Dr Simon Richardson, University of Greenwich, UK
Dr Muhammad Sohail, University of Oxford, UK

World Time Converter: https://www.worldtimebuddy.com